Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Volume: 196

Issue: 10

Year of Publication: 2024

Affiliated Institutions:  Psychiatrist, Department of Psychiatry, University of Calgary, Calgary, Alta. Psychiatrist, Department of Psychiatry, University of Toronto, Toronto, Ont. Psychiatrist, Centre for Addiction and Mental Health, Toronto, Ont.

Abstract summary 

Authors & Co-authors:  Bahji Danilewitz Sloan Tang Crockford

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Wood E, Bright J, Hsu K, et al. .; Canadian Alcohol Use Disorder Guideline Committee. Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder. CMAJ 2023;195:E1364–79.
Authors :  5
Identifiers
Doi : 10.1503/cmaj.149917-l
SSN : 1488-2329
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
Canada